Researchers identify roots of childhood asthma

Infants who show defective immune responses to microbial components are more likely to acquire asthma later in childhood, according to a study of 541 children.

Read more

Valneva raises US$85m

French vaccine developer Valneva SA will raise $85m in a financing arrangement with Deerfield and OrbiMed and go Nasdaq to co-fund its Lyme disease programme.

Read more

EMA greenlights 15 new meds

The EMA’s human medicines committee (CHMP) recommended fifteen medicines for approval at its January 2020 meeting.

Read more

Sleeping sickness target deciphered

Researchers at the University of Luebeck have revealed the structure of the IMP dehydrogenase, a central target of T. brucei, which causes sleeping sickness.

Read more

UK researchers present dengue virus transmission map

Scientists at Imperial College London have created a worldwide atlas of dengue virus transmission with much higher spatial resolution than any previous regional- or global-scale estimates.

Read more

AMR: IMI’s Enable project reaches endpoints

The ENABLE project has achieved its initial goals to identify three antibacterial leads, select two antibacterial development candidates and advance one compound into Phase I development.

Read more

MercachemSyncom, Bionetix, and ProQinase ink AML contract

Bionetix, ProQinase, and MercachemSyncom have announced that they will jointly develop a new AML drug, from target identification to clinical testing

Read more